kpcxm18
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT04629287)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07279493 | Phase 2 | Nov 22, 2025 | Capital Medical University, Kunming Pharmaceuticals, Inc. |
| NCT05745311 | Phase 2 | Mar 1, 2023 | Capital Medical University, Kunming Pharmaceuticals, Inc. |
| NCT04629287 | Phase 1 | Nov 30, 2020 | Kunming Pharmaceuticals, Inc., Tianjin University of Traditional Chinese Medicine |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kunming Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2020 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 1 | 2023 |
| Tianjin University of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1